Aims and Scope
The field of interventional cardiology has been characterized by innovation and technological progress in recent years. Clinicians, in partnership with specialists in molecular biology, biomedical engineering, biophysics and imaging technology, have raised the profile of interventional cardiology to the extent that it is now one of the most vibrant and dynamic subspecialties in mainstream medical practice. As the field matures, the range of opportunities and applications continues to broaden, and there is an increasing need to focus not only on the effectiveness of treatment, but on safety issues; for example drug-eluting stent thrombosis. Given the integrated nature of this evolving field we can expect growing emphasis on a multidisciplinary approach, and, further ahead, there are tantalizing prospects in the emerging technologies from stem cell research and regenerative medicine.
Interventional Cardiology charts the advances as they unfold and provides a unique resource for interventionalists seeking to keep pace with the unfolding technologies.
Articles published in Interventional Cardiology cover key areas such as:
- Imaging technologies
- Angioplasty and stenting
- Drug-eluting stents
- Catheterization techniques
- Embolic protection
- Peripheral arterial disease
- Percutaneous mitral valve replacement and repair
- Endovascular repair
- Treatment of arrhythmias, including cardiac resynchronization and pacing devices
- Cell therapy
Strategies for cardiovascular patient care have been revolutionized by interventional cardiology. Interventional Cardiology will provide a forum for commentary, debate and new findings as the scope of applications becomes increasingly complex.
Indexed in: EMBASE/Excerpta Medica; Scopus
Current Volume: This journal has ceased publication
Issues per Year: 6
Average Abstract Views: 1,988 (January 2015 - December 2015)
Open Access Option: For all article types except for Drug or Device Evaluations
Average Lead Time to Online Publication: 14 - 16 weeks
Rapid Publication Option: Yes